Although targets like Her2, ER, or PR are promising molecules in the treatment of certain breast cancers, there is still a need to explore the role of other proteins and to analyze their molecular mechanism in breast cancer development in order to understand the disease and develop effective targeted therapies for breast cancer patients. This evidence concerns the gene ERBB2 and breast cancer.